Immunicon Overview

  • Founded
  • 1984
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 96
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $31M
Latest Deal Amount

Immunicon General Information

Description

Developer and manufacturer of cell-based diagnostic and research products. The company manufactures ultra-high sensitive cancer detection test kits (cancer blood test) and next generation cell analysis instruments (cell track cytometer) for various research and clinical applications.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Discovery Tools (Healthcare)
Acquirer
Veridex
Primary Office
  • 3401 Masons Mill Road
  • Suite 100
  • Huntingdon Valley, PA 19006
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunicon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Aug-2008 $31M 0000 Completed Generating Revenue/Not Profitable
6. Bankruptcy: Admin/Reorg 11-Jun-2008 Completed Bankruptcy: Admin/Reorg
5. IPO 16-Apr-2004 000.00 Completed Generating Revenue
4. Later Stage VC (Series F) 01-Jul-2003 000.00 000.00 Completed Generating Revenue
3. Later Stage VC 01-Jan-2002 000.00 000.00 Completed Generating Revenue
2. Later Stage VC 11-Sep-2000 $21.8M $31.8M Completed Generating Revenue
1. Later Stage VC (Series D) 01-Jan-1999 $10M $10M Completed Generating Revenue
To view Immunicon’s complete valuation and funding history, request access »

Immunicon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunicon Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Anthem Capital Management Venture Capital Minority 000 0000 000000 0
Burrill & Co Merchant Banking Firm Minority 000 0000 000000 0
Canaan Partners Venture Capital Minority 000 0000 000000 0
Claneil Enterprises Holding Company Minority 000 0000 000000 0
Equity4Life Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »